Surge In Travel And Tourism Drives Growth Of The Travel Vaccine Market: An Emerging Driver Transforming The Travel Vaccines Market Landscape

The Travel Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Travel Vaccines Market Size During the Forecast Period?
Over the recent years, the market size for travel vaccines has seen a robust expansion. The forecast for growth goes from $4.73 billion in 2024 to $5.14 billion in 2025, with an 8.6% compound annual growth rate (CAGR). This growth during the historic period can be associated with the rise in international travel, government strategies for travel health, the worldwide spreading of diseases, an increase in awareness amongst travellers, and the rapid expansion of the travel and tourism industry.

Expectations are high for significant expansion in the travel vaccines market within the forthcoming years. The prediction is that by 2029, this market will have increased to $7.49 billion, with a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this projected growth include the escalating frequency of corporate travel, the threat posed by emerging infectious diseases, government policy stipulations and ingress prerequisites, amplified interest in exotic travel destinations, and joint efforts by government bodies and pharmaceutical corporations. The period under forecast also signals trends like personalised vaccination techniques, market penetration into non-endemic regions, the application of digital health technology, regulatory backing, streamlined approval procedures, and ground-breaking developments.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

What Are the High-Growth Segments in the Travel Vaccines Market?
The travel vaccines market covered in this report is segmented -

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel

Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Key Drivers Are Expected to Influence Future Travel Vaccines Market Growth?
The surge in travel and tourism activities is projected to stimulate the expansion of the market for travel vaccines. The term travel and tourism essentially describes the translocation of individuals or objects, encompassing modes of transport such as trains, boats, airplanes, and various other vehicles across distinct geographical locations. Travel vaccines play a crucial role for tourists and travellers, ensuring their safety and health during their overseas journeys. For example, the United Nations World Tourism Organization (UNWTO), an intergovernmental body promoting tourism based in Spain, reported in January 2023 that over 900 million tourists had travelled internationally in 2022. This figure is double that of 2021 and still 63% higher than levels recorded before the pandemic. Consequently, the surge in travel and tourism activities is serving as a key driving factor behind the growth of the travel vaccine market.

Which Companies Hold the Largest Share Across Different Travel Vaccines Market Segments?
Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

What Trends Are Driving Growth in The Travel Vaccines Market?
Product innovation is emerging as a dominant trend in the travel vaccine industry. Top players in the sector are creating groundbreaking vaccines in order to maintain their relevance in the market. For example, in August 2022, Takeda Pharmaceutical Company Limited, a pharmaceutical organization based in Japan, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), designed to prevent dengue fever from any serotype in individuals aged between six and 45. This was authorized by the Indonesia National Agency for Drug and Food Control. Regardless of an individual's prior exposure to the disease, QDENGA proved to offer continual protection against dengue fever and related hospitalizations three years post-immunization.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Are the Emerging Geographies for The Travel Vaccines Market Growth?
North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Travel Vaccines Market?
2. What is the CAGR expected in the Travel Vaccines Market?
3. What Are the Key Innovations Transforming the Travel Vaccines Industry?
4. Which Region Is Leading the Travel Vaccines Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.